Related Experiment Videos

"Have you seen this?" Diffuse hepatic apoptosis

P Greaves1, R Edwards, G M Cohen

  • 1MRC Toxicology Unit, University of Leicester, United Kingdom.

Toxicologic Pathology
|July 10, 2001
PubMed

Insights

Fas receptor activation triggers massive apoptosis in mouse livers, a process blocked by the caspase inhibitor Z-VAD.fmk. This suggests apoptosis plays a key role in severe liver disease.

Area of Science:

  • Cell biology
  • Immunology
  • Hepatology

Background:

  • The Fas receptor is a key mediator of programmed cell death.
  • Caspases are essential enzymes in the execution of apoptosis.

Purpose of the Study:

  • To investigate the role of Fas-mediated apoptosis in liver injury.
  • To determine the effect of caspase inhibition on Fas-induced liver apoptosis.

Main Methods:

  • Balb/c mice were treated with anti-Fas antibody alone or with the caspase inhibitor Z-VAD.fmk.
  • Tissues were analyzed for apoptosis and cleaved caspase-3 expression via histology and immunocytochemistry.

Main Results:

  • Anti-Fas antibody induced massive apoptosis and cleaved caspase-3 staining in mouse livers.
  • Co-administration of Z-VAD.fmk significantly reduced Fas-induced apoptosis and caspase-3 activation.
  • Control groups showed minimal apoptosis or caspase-3 staining.

Conclusions:

  • Fas-mediated apoptosis is a critical pathway in inducing liver cell death.
  • Inhibiting caspases can prevent Fas-induced massive apoptosis.
  • These findings highlight the potential role of apoptosis in fulminant liver disease.

Related Concept Videos